Borowczak, J.; Łaszczych, D.; Olejnik, K.; Michalski, J.; Gutowska, A.; Kula, M.; Bator, A.; Sekielska-Domanowska, M.; Makarewicz, R.; Marszałek, A.;
et al. Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies. Pharmaceuticals 2024, 17, 1304.
https://doi.org/10.3390/ph17101304
AMA Style
Borowczak J, Łaszczych D, Olejnik K, Michalski J, Gutowska A, Kula M, Bator A, Sekielska-Domanowska M, Makarewicz R, Marszałek A,
et al. Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies. Pharmaceuticals. 2024; 17(10):1304.
https://doi.org/10.3390/ph17101304
Chicago/Turabian Style
Borowczak, Jędrzej, Dariusz Łaszczych, Katarzyna Olejnik, Jakub Michalski, Anna Gutowska, Monika Kula, Anita Bator, Marta Sekielska-Domanowska, Roman Makarewicz, Andrzej Marszałek,
and et al. 2024. "Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies" Pharmaceuticals 17, no. 10: 1304.
https://doi.org/10.3390/ph17101304
APA Style
Borowczak, J., Łaszczych, D., Olejnik, K., Michalski, J., Gutowska, A., Kula, M., Bator, A., Sekielska-Domanowska, M., Makarewicz, R., Marszałek, A., Szylberg, Ł., & Bodnar, M.
(2024). Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies. Pharmaceuticals, 17(10), 1304.
https://doi.org/10.3390/ph17101304
